Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00640) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
FK-435
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 3 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3033767"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Cytochrome P450 1B1 (CYP1B1) | DME Info | Homo sapiens | [1] | |||
| Cytochrome P450 3A4 (CYP3A4) | DME Info | Homo sapiens | [1] | |||
| Cytochrome P450 3A5 (CYP3A5) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites. Xenobiotica. 2002 Oct;32(10):863-78. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.